Cargando…

Aurora Kinase A-YBX1 Synergy Fuels Aggressive Oncogenic Phenotypes and Chemoresistance in Castration-Resistant Prostate Cancer

Multifunctional protein YBX1 upregulation promotes castration-resistant prostate cancer (CRPC). However, YBX1 protein abundance, but not its DNA status or mRNA levels, predicts CRPC recurrence, although the mechanism remains unknown. Similarly, the mechanism by which YBX1 regulates androgen receptor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nikhil, Kumar, Raza, Asif, Haymour, Hanan S., Flueckiger, Benjamin V., Chu, Jiachong, Shah, Kavita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140108/ https://www.ncbi.nlm.nih.gov/pubmed/32178290 http://dx.doi.org/10.3390/cancers12030660

Ejemplares similares

Phosphorylation-dependent regulation of SPOP by LIMK2 promotes castration-resistant prostate cancer
por: Nikhil, Kumar, et al.
Publicado: (2020)

Molecular Interplay between AURKA and SPOP Dictates CRPC Pathogenesis via Androgen Receptor
por: Nikhil, Kumar, et al.
Publicado: (2020)

YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia
por: Li, Huan, et al.
Publicado: (2023)

SIAH1 reverses chemoresistance in epithelial ovarian cancer via ubiquitination of YBX-1
por: Gao, Wujiang, et al.
Publicado: (2022)

Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1
por: Kishikawa, Takahiro, et al.
Publicado: (2016)

YBX1 mediates translation of oncogenic transcripts to control cell competition in AML
por: Perner, Florian, et al.
Publicado: (2021)

Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance
por: Jalalirad, Mohammad, et al.
Publicado: (2021)

Physiological and Oncogenic Aurora-A Pathway
por: SAEKI, Toshiaki, et al.
Publicado: (2009)

Identification of RNA-binding protein YBX3 as an oncogene in clear cell renal cell carcinoma
por: Wang, Chen, et al.
Publicado: (2023)

YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer
por: Suzuki, Izumi, et al.
Publicado: (2021)

CDK5: an oncogene or an anti-oncogene: location location location
por: Nikhil, Kumar, et al.
Publicado: (2023)

Identification and verification of YBX3 and its regulatory gene HEIH as an oncogenic system: A multidimensional analysis in colon cancer
por: Sun, Yiming, et al.
Publicado: (2022)

YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells
por: Bai, Yuchen, et al.
Publicado: (2023)

Apoptosis – Fueling the oncogenic fire
por: Castillo Ferrer, Camila, et al.
Publicado: (2020)

Aurora Borealis (Bora), Which Promotes Plk1 Activation by Aurora A, Has an Oncogenic Role in Ovarian Cancer
por: Parrilla, Alfonso, et al.
Publicado: (2020)

Aurora-A Induces Chemoresistance Through Activation of the AKT/mTOR Pathway in Endometrial Cancer
por: Wu, Jun, et al.
Publicado: (2019)

The Pleiotropic Effects of YBX1 on HTLV-1 Transcription
por: Smith, Susan, et al.
Publicado: (2023)

Aurora A regulates expression of AR-V7 in models of castrate resistant prostate cancer
por: Jones, Dominic, et al.
Publicado: (2017)

Mechanistic Insights into Chemoresistance Mediated by Oncogenic Viruses in Lymphomas
por: Chen, Jungang, et al.
Publicado: (2019)

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer
por: Gordon, Nicolas, et al.
Publicado: (2023)

Ghrelin Upregulates Oncogenic Aurora A to Promote Renal Cell Carcinoma Invasion
por: Lin, Tsung-Chieh, et al.
Publicado: (2019)

Epithelial to Mesenchymal Transition: A Mechanism that Fuels Cancer Radio/Chemoresistance
por: Dudás, József, et al.
Publicado: (2020)

Transcriptional and post-transcriptional control of autophagy and adipogenesis by YBX1
por: Wu, Ruifan, et al.
Publicado: (2023)

Phosphorylated YBX2 is stabilized to promote glycolysis in brown adipocytes
por: Zhao, Qingwen, et al.
Publicado: (2023)

The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53
por: Yi, Joanna S., et al.
Publicado: (2021)

LINC00312/YBX1 Axis Regulates Myofibroblast Activities in Oral Submucous Fibrosis
por: Yu, Chuan-Hang, et al.
Publicado: (2020)

MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance
por: Marengo, Barbara, et al.
Publicado: (2019)

Phosphorylation-dependent regulation of ALDH1A1 by Aurora kinase A: insights on their synergistic relationship in pancreatic cancer
por: Wang, Jing, et al.
Publicado: (2017)

Synergies of fuel cell system thermal management and cryogenic hydrogen exergy utilization
por: Lenger, Magnus, et al.
Publicado: (2022)

Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance
por: Giddings, Emily L., et al.
Publicado: (2021)

YBX1 Is a Modulator of MIA/CD-RAP-Dependent Chondrogenesis
por: Schmid, Rainer, et al.
Publicado: (2013)

Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation
por: Currier, Mark A., et al.
Publicado: (2017)

Aurora /
por: López Colomé, Pura, 1952-
Publicado: (1994)

Aurora
por: Böhme, Jacob
Publicado: (1979)

Aurora /
por: Leiris, Michel, 1901-
Publicado: (1977)

Aurora
por: Nietzsche, Friedrich Wilhelm, 1844-1900
Publicado: (1996)

Aurora
por: Jones, Alister Vallance
Publicado: (1974)

Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior
por: Mobley, Aaron, et al.
Publicado: (2017)

PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma
por: Shen, Bin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vsdlqb5n2oedubk827mjugkp6g